Though they may sound similar, NAD and NAC provide distinct benefits that work in different ways to promote your health
Butyrate administered in pharmacological doses (5 mM) directly to ex vivo rat islets can increase GSIS (Wang et al., 2022), but this effect might potentially be due to mechanisms unrelated to its binding to FFARs, such as on chromatin remodelling (Priyadarshini et al., 2015), found that primary isolated wild-type mouse islets secrete 50% more insulin in a GSIS assay following co-stimulation with acetate and Exendin-4 compared to FFA2 KO islets
Most common side effects (according to the company's safety information): Nausea, vomiting, diarrhea, constipation, bloating or gas, and decreased appetite or early satiety
The GLP-1 receptor effect on gut motility GLP-1 receptor activation is the primary driver of gastrointestinal side effects in retatrutide, just as it is in pure GLP-1 agonists like semaglutide and dual agonists like tirzepatide